Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | CNR2 | P34972 | 3/20 | 0.44 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.43 |
| ▸ | BCHE | P06276 | 2/20 | 0.43 |
| ▸ | ACHE | P22303 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.42 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | APP | P05067 | 1/20 | 0.40 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.40 |
| ▸ | CNR1 | P21554 | 1/20 | 0.40 |
| ▸ | RORC | P51449 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7801499 | 0.86 | ALDH1A1 (0.55) | LMNACNR2ACHEKDM4ETMEM97 | |
| SCHEMBL7795548 | 0.78 | KDM4E (0.43) | CNR2HRH3BCHEACHEKDM4E | |
| Chloromethane SCHEMBL27279684 | 0.77 | HRH3 (0.60) | LMNACNR2HRH3BCHEKDM4E | |
| SCHEMBL11366830 | 0.77 | HRH3 (0.67) | HRH3ALDH1A1 | |
| SCHEMBL632439 | 0.77 | CNR2 (0.48) | LMNACNR2KDM4EMEN1KMT2A | |
| SCHEMBL81248 | 0.77 | HRH3 (0.65) | LMNACNR2HRH3BCHEKDM4E | |
| SCHEMBL6553827 | 0.76 | CNR2 (0.51) | CNR2HRH3BCHEACHEKDM4E | |
| SCHEMBL28253555 | 0.75 | LMNA (0.52) | LMNAKDM4ESIGMAR1TSHRMEN1 | |
| Trimethylammonium SCHEMBL7802299 | 0.75 | CNR2 (0.49) | LMNACNR2TSHRMEN1KMT2A | |
| Fluoride SCHEMBL11307410 | 0.75 | HRH3 (0.62) | LMNACNR2HRH3BCHEKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20010012899-A1 | Oligomeric methine dyes | CLARIANT FINANCE ( BVI) LIMITED | 2001-08-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010012899-A1 | Oligomeric methine dyes | INMT, DDT, DDC | LMNA 2157/4885CNR2 3039/4885HRH3 1120/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.